Skip to main content
. 2015 Feb 4;30(8):1081–1096. doi: 10.1007/s11606-015-3199-4

Table 1.

Study Cohort Characteristics

Characteristics Any drug overdose event* Total
No (N = 205,484) Yes (N = 1385) (N = 206,869)
Demographics
 Women, n (%) 116,585 (56.7) 887 (64.0) 117,472 (56.8)
 Age, mean (SD) 44.1 (12.0) 42.5 (12.4) 44.1 (12.0)
 U.S. Region, n (%)
  Midwest 11,950 (5.8) 78 (5.6) 12,028 (5.8)
  Northeast 60,146 (29.3) 421 (30.4) 60,567 (29.3)
  South 96,413 (46.9) 659 (47.6) 97,072 (46.9)
  West 36,975 (18.0) 227 (16.4) 37,202 (18.0)
Clinical conditions, n (%)
 Non-cancer pain conditions
  Large joint arthritis, other musculoskeletal 101,577 (49.4) 739 (53.4) 102,316 (49.5)
  Back pain 79,801 (38.8) 722 (52.1) 80,523 (38.9)
  Neuropathy 1762 (0.9) 26 (1.9) 1788 (0.9)
  Chronic pain (unspecified) 13,874 (6.8) 337 (24.3) 14,211 (6.9)
  Headache 14,460 (7.0) 175 (12.6) 14,635 (7.1)
 Mental health and substance use disorders
  Anxiety or post-traumatic stress disorder 30,308 (14.8) 579 (41.8) 30,887 (14.9)
  Depression 25,466 (12.4) 757 (54.7) 26,223 (12.7)
  Psychosis 5268 (2.6) 335 (24.2) 5603 (2.7)
  Alcohol abuse 4283 (2.1) 354 (25.6) 4637 (2.2)
  Other substance abuse 4044 (2.0) 376 (27.2) 4420 (2.1)

* P value for comparison of all variables was <0.001 except for region (0.43)

Clinical conditions diagnosed at any point in study time frame. ICD-9-CM codes available from authors

Arthritis, arthralgia, fracture, sprains